GMED
Globus Medical
73.80$
-3.5%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 12.6% | 24.7% | 23.1% | 19.8% | 21.5% | 16.7% | 22.4% | 30.5% | 25.1% | 25.5% | 21.9% | 25.2% | 28.8% | 17.4% | 15.5% | 20.7% | 25.6% | |
| 5.3% | 5.3% | 5.1% | 4.7% | 4.5% | 4.6% | 4.4% | 6.9% | 6.6% | 5.8% | 6.7% | 8.0% | 7.3% | 6.7% | 9.2% | 10.1% | 9.4% | |
| 1.4% | 1.4% | 1.0% | 1.2% | 1.2% | 1.5% | 1.8% | 2.0% | 2.3% | 3.1% | 3.3% | 3.4% | 3.2% | 3.2% | 3.4% | 2.2% | 1.7% | |
| – | – | – | 1.3% | -0.2% | 2.1% | 4.6% | 4.8% | 6.4% | 4.5% | 4.8% | 9.0% | 7.5% | 2.2% | – | – | – | |
| -15.6% | -3.7% | -5.2% | -5.3% | 1.4% | -10.1% | -8.0% | 0.6% | -4.8% | -7.0% | -9.4% | -4.8% | -1.8% | -10.3% | -7.4% | -3.9% | -2.8% | |
| 10.2% | 4.3% | 6.8% | 6.4% | 5.5% | 5.2% | 9.3% | 7.3% | 8.1% | 8.4% | 9.0% | 8.1% | 5.9% | 7.2% | 5.0% | 4.6% | 5.6% | |
| -10.9% | -4.2% | -9.0% | -8.0% | -52.3% | -21.1% | -27.6% | -17.7% | -17.5% | -27.1% | -17.9% | -14.9% | -39.2% | -10.8% | 19.3% | -7.0% | -12.1% | |
| – | – | – | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | – | – | – | – | – | – | – | – | |
| – | – | -3.0% | 0.4% | 1.7% | 2.1% | 1.0% | 1.0% | 1.8% | 5.5% | 4.0% | -13.3% | 6.6% | -14.1% | -14.4% | -3.4% | -10.2% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | 0.0% | 0.0% | -15.3% | |
| 0.6% | 0.6% | -4.4% | 6.2% | 2.5% | 2.7% | 1.2% | 0.4% | 0.3% | 4.6% | 3.1% | -4.9% | 5.7% | -10.8% | -14.8% | -1.1% | -23.1% | |
| 2.3% | 21.2% | 9.3% | 18.1% | -28.2% | -1.6% | -4.1% | 12.9% | 8.2% | 2.9% | 7.1% | 5.5% | -4.8% | -4.2% | 20.2% | 12.6% | -8.8% | |
| 2.4% | 20.5% | 16.3% | 13.4% | 16.1% | 11.5% | 13.1% | 23.2% | 17.0% | 17.1% | 12.9% | 17.1% | 22.9% | 10.2% | 10.5% | 16.1% | 20.0% |
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.